Older colorectal cancer patients on Medicare who saw their primary care physician more often were less likely to die from colorectal cancer and from other illnesses.
They were almost three times as likely to have been screened and more likely to be diagnosed early. Read the rest of this entry »
Colorectal cancer patients in a phase III clinical trial who took the oral drug regorafenib lived longer than those who got the best supportive care along with a placebo.
In fact, when the independent Data Monitoring Committee analyzed the progress of the trial, they recommended it be unblinded so that patients who had been randomly assigned to supportive care and a placebo pill could receive the new medicine.
The survival benefit was statistically significant, although how much time was gained isn’t yet available. Overall survival benefits are expected to be reported at an upcoming scientific meeting.
Patients enrolled in the randomized Phase III CORRECT trial had already had their cancer get worse on all standard approved treatments. Read the rest of this entry »
CancerCare is offering a teleconference in collaboration with Fight Colorectal Cancer:
A panel of experts will cover topics including new treatments for colorectal cancer, clinical trials, personalized medicine, nutrition, controlling symptoms and pain, and communicating with your healthcare team.
Need some help with keeping the house clean during cancer treatment?
Sometimes trying to clean the kitchen or vacuum the living room is just too darn much . . . especially during chemo or after surgery. Things get cluttered and grimy, and you get exhausted and discouraged.
There are organizations that can help. Read the rest of this entry »
A small study has found ginger supplements reduce markers of inflammation in the colon tissue of 30 healthy volunteers..
There is a lot we don’t know. Yet, ginger is being touted by the media as preventing or fighting colon cancer. True, many headlines are hedging bets with words like “may” but the implication is still there.
